Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion

Genes Chromosomes and Cancer

Volumn 55, Issue 3, 2016, Pages 227-236

  Alarmo, Emma Leena ^a,b   Havunen, Riikka ^a,b   Häyrynen, Sergei ^a   Penkki, Sanna ^a,b   Ketolainen, Johanna ^a,b   Nykter, Matti ^a   Kallioniemi, Anne ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FIMLAB LABORATORIES   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; MICRORNA; MICRORNA 106B 5P; MICRORNA 16 5P; MICRORNA 23A 3P; MICRORNA 23B 3P; UNCLASSIFIED DRUG; BMP4 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; BT 474 CELL LINE; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HCC1954 CELL LINE; HUMAN; HUMAN CELL; MCF 10A CELL LINE; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MDA MB 361 CELL LINE; MDA MB 436 CELL LINE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T 47D CELL LINE; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BONE MORPHOGENETIC PROTEIN 4; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; MICRORNAS;

EID: 84954361128     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22324     Document Type: Article

References (51)

1. Ahmed MI, Mardaryev AN, Lewis CJ, Sharov AA, Botchkareva NV. 2011. MicroRNA-21 is an important downstream component of BMP signalling in epidermal keratinocytes. J Cell Sci 124:3399-3404.
2. Alarmo EL, Huhtala H, Korhonen T, Pylkkanen L, Holli K, Kuukasjarvi T, Parkkila S, Kallioniemi A. 2013. Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development. Mod Pathol 26:10-21.
3. Ameres SL, Zamore PD. 2013. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 14:475-488.
4. Ampuja M, Jokimaki R, Juuti-Uusitalo K, Rodriguez-Martinez A, Alarmo EL, Kallioniemi A. 2013. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment. BMC Cancer 13: 429.
5. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: A critical review. Cell Signal 23:609-620.
6. Brazil DP, Church RH, Surae S, Godson C, Martin F. 2015. BMP signalling: Agony and antagony in the family. Trends Cell Biol 25:249-264.
7. Cao Y, Slaney CY, Bidwell BN, Parker BS, Johnstone CN, Rautela J, Eckhardt BL, Anderson RL. 2014. BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Res 74:5091-5102.
8. Carreira AC, Alves GG, Zambuzzi WF, Sogayar MC, Granjeiro JM. 2014. Bone morphogenetic proteins: structure, biological function and therapeutic applications. Arch Biochem Biophys 561:64-73.
9. Chhabra R, Dubey R, Saini N. 2010. Cooperative and individualistic functions of the microRNAs in the miR-23a∼27a∼24-2 cluster and its implication in human diseases. Mol Cancer 9: 232.
10. Davis BN, Hilyard AC, Lagna G, Hata A. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61.
11. Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256-268.
12. Di Leva G, Garofalo M, Croce CM. 2014. MicroRNAs in cancer. Annu Rev Pathol 9:287-314.
13. Du J, Yang S, An D, Hu F, Yuan W, Zhai C, Zhu T. 2009. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. Cell Res 19:487-496.
14. Eissa S, Matboli M, Shehata HH. 2015. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer. Transl Res 165:417-427.
15. Ell B, Qiu Q, Wei Y, Mercatali L, Ibrahim T, Amadori D, Kang Y. 2014. The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. J Biol Chem 289:21888-21895.
16. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
17. Gong C, Qu S, Liu B, Pan S, Jiao Y, Nie Y, Su F, Liu Q, Song E. 2015. MiR-106b expression determines the proliferation paradox of TGF-beta in breast cancer cells. Oncogene 34:84-93.
18. Guo D, Huang J, Gong J. 2012. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. Mol Cell Biochem 363:179-190.
19. Ha M, Kim VN. 2014. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509-524.
20. Hata A, Kang H. 2015. Functions of the bone morphogenetic protein signaling pathway through microRNAs (review). Int J Mol Med 35:563-568.
21. Hu F, Meng X, Tong Q, Liang L, Xiang R, Zhu T, Yang S. 2013. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer. Biochim Biophys Acta 1832:2379-2390.
22. Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP. 2014. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Gene 552:255-264.
23. Jansson MD, Lund AH. 2012. MicroRNA and cancer. Mol Oncol 6:590-610.
24. Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SK. 2013. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer. Cancer Res 73:2884-2896.
25. Kallioniemi A. 2012. Bone morphogenetic protein 4 - a fascinating regulator of cancer cell behavior. Cancer Genet 205:267-277.
26. Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery BN, Lagna G, Hata A. 2012. Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J Biol Chem 287:38656-38664.
27. Ketolainen JM, Alarmo EL, Tuominen VJ, Kallioniemi A. 2010. Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Res Treat 124:377-386.
28. Laurila EM, Sandstrom S, Rantanen LM, Autio R, Kallioniemi A. 2012. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer 51:557-568.
29. Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, Lobie PE, Zhu T. 2013. c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 288:18121-18133.
30. Liu X, Gu X, Sun L, Flowers AB, Rademaker AW, Zhou Y, Kiyokawa H. 2014. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis. BMC Cancer 14: 57.
31. Lujambio A, Lowe SW. 2012. The microcosmos of cancer. Nature 482:347-355.
32. McDermott AM, Kerin MJ, Miller N. 2013. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies. PLoS One 8:e83718
33. Miyazono K, Kamiya Y, Morikawa M. 2010. Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35-51.
34. Mobarra N, Shafiee A, Rad SM, Tasharrofi N, Soufi-Zomorod M, Hafizi M, Movahed M, Kouhkan F, Soleimani M. 2015. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells. In Vitro Cell Dev Biol Anim 51:604-611.
35. Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. 2013. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol 229:449-459.
36. Musto A, Navarra A, Vocca A, Gargiulo A, Minopoli G, Romano S, Romano MF, Russo T, Parisi S. 2015. miR-23a, miR-24 and miR-27a protect differentiating ESCs from BMP4-induced apoptosis. Cell Death Differ 22:1047-1057.
37. Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X, Ding Q, Zha X, Sha J, Wang S. 2014. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2. Cancer Sci 105:18-25.
38. Pal A, Huang W, Li X, Toy KA, Nikolovska-Coleska Z, Kleer CG. 2012. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res 72:4818-4828.
39. Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L, Jiao LR, Periyasamy M, Madsen CD, Caley MP, Ottaviani S, Roca-Alonso L, El-Bahrawy M, Coombes RC, Krell J, Castellano L. 2013. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res 41:5400-5412.
40. Pincini A, Tornillo G, Orso F, Sciortino M, Bisaro B, Leal Mdel P, Lembo A, Brizzi MF, Turco E, De Pitta C, Provero P, Medico E, Defilippi P, Taverna D, Cabodi S. 2013. Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells. Cell Cycle 12:2409-2422.
41. Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV. 2012. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 14:R77
42. Rodriguez-Martinez A, Alarmo EL, Saarinen L, Ketolainen J, Nousiainen K, Hautaniemi S, Kallioniemi A. 2011. Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes. BMC Med Genomics 4: 80-8794-4-80.
43. Schmierer B, Hill CS. 2007. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970-982.
44. Serpico D, Molino L, Di Cosimo S. 2014. microRNAs in breast cancer development and treatment. Cancer Treat Rev 40:595-604.
45. Shin VY, Siu JM, Cheuk I, Ng EK, Kwong A. 2015. Circulating cell-free miRNAs as biomarker for triple-negative breast cancer. Br J Cancer 112:1751-1759.
46. Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS. 2009. Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 385:198-203.
47. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL. 2012. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 31:5162-5171.
48. Steinert S, Kroll TC, Taubert I, Pusch L, Hortschansky P, Hoffken K, Wolfl S, Clement JH. 2008. Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2. J Cancer Res Clin Oncol 134:1237-1245.
49. Stuckrath I, Rack B, Janni W, Jager B, Pantel K, Schwarzenbach H. 2015. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 6:13387-13401.
50. Zheng R, Pan L, Gao J, Ye X, Chen L, Zhang X, Tang W, Zheng W. 2015. Prognostic value of miR-106b expression in breast cancer patients. J Surg Res 195:158-165.
51. Zhou Y, Hu Y, Yang M, Jat P, Li K, Lombardo Y, Xiong D, Coombes RC, Raguz S, Yague E. 2014. The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300. Cell Death Differ 21:462-474.